Hints and tips:
Related Special Reports
The FT’s fifth annual ranking of the region’s businesses by revenue growth. Plus: outsourcers tap into remote work boom; Shopify targets more growth from bigger clients; Brazil’s alternative to electric vehicles; and Vertex Pharmaceutical’s potential answer to the opioid crisis
...WPP’s Ogilvy advertising agency is creating a division specialising in online “health influencers” to help pharmaceutical companies tap a trend towards personalised health and combat misinformation....
...Soriot already earns more than bosses of larger European pharmaceutical companies....
...Curaleaf is the world’s largest cannabis company, with a market capitalisation of C$4.6bn, and its shares have risen 40 per cent in the past year....
...So effective is Vertex Pharmaceuticals’ blockbuster cystic fibrosis (CF) drug, Trikafta, that studies project it could extend the lives of some young patients by up to 45 years....
...No concessions of liability have been made,” the company said....
...AstraZeneca has acquired oncology biotech Fusion Pharmaceuticals for $2.4bn to build its expertise and challenge Swiss company Novartis in the developing field of a more targeted form of radiotherapy....
...company’s biggest-selling drugs....
...The UK-based pharmaceutical group reported revenue of $12.7bn for the first quarter of 2024, an increase of 19 per cent, well ahead of consensus estimates of $11.9bn....
...It is a similar milestone-based structure to many partnerships in the pharmaceutical industry....
...Over the decades, studies have repeatedly shown these gender disparities persisting: men are more likely to be prescribed painkillers while women have to make do with psycho-pharmaceutical interventions....
Technique highlights concerns shifting global disease burden as populations age
...“Adrian van den Hoven, director-general of Medicines for Europe, an industry body representing European pharmaceutical companies, said that ambiguity around the new anti-espionage law had led to concerns...
...It needs further deals to replenish its pharmaceuticals pipeline....
...Panuwat’s company, Medivation, was bought in 2016 by Pfizer for $14bn. But the stock he purchased at the time was not that of Medivation....
...The US drugmaker, a top-10 pharma company by sales, relies on WuXi AppTec sister company WuXi Biologics to manufacture some of the active pharmaceutical ingredients in its blockbuster cancer pill Revlimid...
...The case is the latest in a series of intellectual property battles that companies are fighting around the world over mRNA technology, which has helped generate billions in revenues for the pharmaceuticals...
...Emblaveo, marketed in Europe by US pharmaceutical company Pfizer, combines two existing medicines to tackle so-called Gram-negative bacteria that are among the leading drug-resistance threats....
...“The company’s main biological asset are NHPs used for pre-clinical trials....
...A Humira biosimilar from Teva Pharmaceuticals working with Alvotech earlier this year became the first drug that the US Food and Drug Administration granted interchangeable status, which lets pharmacists...
...Many international companies in the consumer goods, pharmaceuticals, retail and manufacturing sectors have continued to do business in Russia, despite a widespread corporate exodus and successive rounds...
...The FDA said the company recalls had been effective and had successfully removed the contaminated batches from the market....
...Last year, at the height of pricing negotiations, leaders from 16 of the world’s largest generic and biosimilar companies wrote asking for clarity on specific aspects of the deal....
...“The biggest barrier is insurance companies,” said Lawrence Honig, a neurologist at New York’s Columbia University Irving Medical Center....
...The company has warned of zero free cash flow for 2023....
International Edition